{
  "id": 14935777,
  "title": "Biogen-backed Estuary nabs $93M for liver disease gene therapy",
  "url": "https://urgent.news/2026/10/16/biogen-backed-estuary-nabs-93m-for-liver-disease-gene-therapy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-16T10:30:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/estuary-kidney-disease-gene-therapy-launch-emerged-biogen-biotech-startup/833114/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Series A round, which was led by RA Capital, will help fund the development of two genetic medicines designed to treat an inherited kidney disorder known as \"ADPKD.\"",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Estuary debuts with $103M to develop kidney disease gene therapies",
        "url": "https://urgent.news/2026/10/16/estuary-debuts-with-103m-to-develop-kidney-disease-gene-therapies",
        "published": "2026-10-16T10:30:34.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}